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Abstract
Background: Gastrointestinal cancer is the first leading cause of cancer related deaths in men and
the second among women in Iran. An investigation was carried out to examine anxiety and
depression in this group of patients and to investigate whether the knowledge of cancer diagnosis
affect their psychological distress.
Methods:  This was a cross sectional study of anxiety and depression in patients with
gastrointestinal cancer attending to the Tehran Cancer Institute. Anxiety and depression was
measured using the Hospital Anxiety and Depression Scale (HADS). This is a widely used valid
questionnaire to measure psychological distress in cancer patients. Demographic and clinical data
also were collected to examine anxiety and depression in sub-group of patients especially in those
who knew their cancer diagnosis and those who did not.
Results: In all 142 patients were studied. The mean age of patients was 54.1 (SD = 14.8), 56% were
male, 52% did not know their cancer diagnosis, and their diagnosis was related to esophagus (29%),
stomach (30%), small intestine (3%), colon (22%) and rectum (16%). The mean anxiety score was
7.6 (SD = 4.5) and for the depression this was 8.4 (SD = 3.8). Overall 47.2% and 57% of patients
scored high on both anxiety and depression. There were no significant differences between gender,
educational level, marital status, cancer site and anxiety and depression scores whereas those who
knew their diagnosis showed a significant higher degree of psychological distress [mean (SD)
anxiety score: knew diagnosis 9.1 (4.2) vs. 6.3 (4.4) did not know diagnosis, P < 0.001; mean (SD)
depression score: knew diagnosis 9.1 (4.1) vs. 7.9 (3.6) did not know diagnosis, P = 0.05].
Performing logistic regression analysis while controlling for demographic and clinical variables
studied the results indicated that those who knew their cancer diagnosis showed a significant higher
risk of anxiety [OR: 2.7, 95% CI: 1.1–6.8] and depression [OR: 2.8, 95% CI: 1.1–7.2].
Conclusion: Psychological distress was higher in those who knew their cancer diagnosis. It seems
that the cultural issues and the way we provide information for cancer patients play important role
in their improved or decreased psychological well-being.
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Background
Cancer is well known to be a difficult disease, affecting
patients and their families both physically and emotion-
ally. Despite biomedical progress, cancer is still often con-
sidered synonymous with death, pain and suffering [1]. It
is argued that cancer is not just a single event with a cer-
tain end but a permanent condition characterized by
ongoing ambiguity, potentially delayed or late effects of
the disease or its treatment and concurrent psychological
issues [2]. Previous studies have demonstrated an
increased risk for psychiatric morbidity among cancer
patients [3,4]. The prevalence of psychiatric disorders in
cancer patients varies greatly among studies ranging from
9% to 60% [3,5,6], although in large studies using stand-
ardized psychiatric interviews and applying research diag-
nostic criteria the range narrows from 10% to 30% [7].
There are few studies that examined anxiety and depres-
sion in gastrointestinal cancer patients. Nordin et al. in
their studies of gastrointestinal cancer patients have
shown that overall 17% of gastrointestinal patients suffer
from anxiety and 21% experience depression and that
those with gastric cancer are more vulnerable to psycho-
logical distress in connection with the diagnosis than are
colorectal cancer patients [8,9]. They also showed that
there are only minor changes over time in the average val-
ues of emotional well being in these patients [10]. In addi-
tion they have indicated that levels of anxiety and
depression at diagnosis could predict a similar status 6
months later [11]. Importantly they found that patients'
satisfaction with life, as defined in terms of the discrep-
ancy between the perceived attainment and subjective
importance of various life values, is associated with anxi-
ety and depression [12]. However, recent studies have
reported that anxiety is more common in younger
patients and depression in those who experience long-
term hospitalization and that coping style might be an
important factor in contributing to the level of anxiety
and depression in gastrointestinal cancer patients [13,14].
The incidence of esophageal and stomach cancer in Iran is
high, well above the world average [15]. It is the first lead-
ing cause of cancer related deaths in men and the second
among women [16]. This paper reports the results of a
study that aimed to investigate about psychological state
of Iranian gastrointestinal cancer patients; and to examine
the relationship between various demographic and clini-
cal factors and psychological distress in this group of
patients. In particular this study aimed to investigate the
role of knowledge about the cancer diagnosis and to com-
pare anxiety and depression in patients who knew their
cancer diagnosis and those who did not.
Methods
Design and data collection
An interview based prospective study was carried out to
measure anxiety and depression in patients with gastroin-
testinal cancer. Data were collected during November
2005 and April 2006. The intention was to interview all
gastrointestinal cancer inpatients attending a large teach-
ing hospital (Imam Hospital) in Tehran, Iran. A psychol-
ogist in a face-to-face interview administered the
questionnaire. Data on demographic characteristics and
clinical information including age, gender, educational
status, cancer site and time since diagnosis were extracted
from case records. To assess patients' knowledge of the
cancer diagnosis, both patients and relatives were investi-
gated separately. This was achieved at the end of each
interview. First we asked relatives to indicate whether a
patient knew his or her diagnosis. Then to confirm this
with patients, after a careful consideration each patient
was asked what was wrong with he or she. Knowledge was
assessed by patients' ability to acknowledge the illness
and use the terms "cancer "or "tumor".
All participants in the study were gastrointestinal cancer
patients who were diagnosed during one year ago.
Patients who had cognitive problems or were too sick to
participate in the interview were excluded. Verbal con-
sents obtained from all patients prior to interview. The
Ethics Committee of the Tehran University of Medical Sci-
ences approved the study.
Instruments
Anxiety and depression was measured using the Hospital
Anxiety and Depression Scale (HADS) [17]. This is a
widely used valid questionnaire to measure psychological
distress in cancer patients [18]. Also it is a brief and well-
established instrument with cut-off suggestive of a psychi-
atric diagnosis [19]. The validation study of the Iranian
version of the HADS proved that it is an acceptable, relia-
ble and valid measure of psychological distress [20]. The
HADS is a 14-item questionnaire consisting of two sub-
scales: anxiety and depression. Each item is rated on a
four-point scale giving maximum scores of 21 for anxiety
and depression. Scores of 11 or more on either subscale
are considered to be a significant "case" of psychological
morbidity, while scores of 8–10 represents "borderline",
and 0–7 "normal". We administered the HADS in an
interview format.
Statistical analysis
The one-way analysis of variance (ANOVA with Bonfer-
roni correction), and independent samples t-test were per-
formed to compare anxiety and depression with regard to
gastrointestinal cancer patients' demographic and clinical
characteristics. In addition logistic regression analysis was
carried out  in order to examine which factors show theBMC Gastroenterology 2007, 7:28 http://www.biomedcentral.com/1471-230X/7/28
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strongest association with anxiety and depression. For the
purpose of the analysis relative to the recommended cut-
off points patients were divided into two groups: those
who scored 0 to 7 as normal and those who scored 8 and
above as probable case [21,22]. Data were analyzed using
the SPSS software version 13.0.
Results
Patients' characteristics
In total 142 patients were studied. The mean age of
patients was 54.1 (SD = 14.8) years, most patients were
married (86%), male (56%), illiterate (55%); and 48%
knew their cancer diagnosis, whereas 52% did not know.
The diagnosis were as fallows: stomach (30%), esophagus
(29%), colon (22%), rectum (16%), and small intestine
(3%). The patients' demographic and clinical characteris-
tics are shown in Table 1.
Anxiety and depression
The mean anxiety score was 7.6 (SD = 4.5) and for depres-
sion this was 8.7 (SD = 3.8). Overall 47.2% and 57%
patients scored high on both anxiety and depression.
There were statistically significant differences between
anxiety and depression and patients' knowledge of diag-
nosis. The results indicated that those who knew their
diagnosis showed a significant higher degree of psycho-
logical distress [mean (SD) anxiety score: knew diagnosis
9.1 (4.2) vs. 6.3 (4.4) did not know diagnosis, P < 0.001;
mean (SD) depression score: knew diagnosis 9.1 (4.1) vs.
7.9 (3.6) did not know diagnosis, P = 0.05]. Considering
patients' demographic status, the findings showed differ-
ent features indicating that there were no statistically sig-
nificant differences between anxiety, depression and
gender, patients' educational level, marital status, and
cancer site. However, age and anxiety showed a significant
relationship (P = 0.005) indicating that patients aged
between 30 to 39 were more anxious compared with oth-
ers. The results are shown in Table 2.
Finally, performing regression analysis both anxiety and
depression showed the strongest association with knowl-
edge of diagnosis (odds ratio for anxiety: 2.7, 95% CI:
1.1–6.8, P = 0.03; odds ratio for depression: 2.8, 95% CI:
1.1–7.2, P = 0.03). No other variables studied showed sig-
nificant results. The results are presented in Table 3.
Discussion
The main finding of the current study was the fact that we
observed the lower levels of anxiety and depression in
patients who did not know their cancer diagnosis. Simi-
larly in Turkey and India it has been demonstrated that
psychiatric disorders occur to lesser extent in patients who
are not aware of their cancer diagnosis. The authors con-
cluded that these patients had a more hopeful outlook to
the outcome of treatment [23,24]. It is argued that since
the majority of physicians in Iran do not inform caner
patients about their true nature of illness, most patients
who know their diagnosis obtain information indirectly,
and thus this might lead to the higher level of emotional
distress in patients who become aware of their illness
[25,26]. However, a study of patients with advanced can-
cer suggested that awareness of prognosis does not itself
cause depression [27].
The low level of knowledge of cancer diagnosis (48%) in
this study was similar to those reported from Middle East
countries [28,29]. One explanation for this finding could
be due to the fact that in developing countries such as Iran
the medical team cannot effectively address cancer
patients' wishes and needs. The other main reason for not
informing patients is that most people in Iran, as in many
Middle East or Asian countries, interpret the diagnosis of
cancer as equivalent to death and therefore patients' fam-
ilies may request physicians not to tell the patient the
diagnosis and the word cancer [25,26]. A study in Nepal
found that 63% of cancer patients were unaware of the
nature of their disease while a survey of the general popu-
lation showed that 80% of the respondents wanted to be
informed if they were diagnosed with cancer [30]. Simi-
larly, cancer patients in Taiwan expressed a strong prefer-
ence for health care professionals to inform them of
disease related information before disclosing information
to their family members [31]. It has been suggested that
the arguments that cancer patients from Asian cultures
have different preferences regarding being informed of
their cancer diagnosis and that family members have legit-
imate superior power in decision-making could not be
supported from studies compiling data from these coun-
tries [32]. However, evidence suggests that sensible disclo-
sure of diagnosis and prognosis is important and
satisfaction with information-giving is associated with a
better quality of life [33]. In addition, there seems to be a
strong relationship between illiteracy and not knowing
the diagnosis. The relevance of level of education and
knowledge of cancer diagnosis seems worthwhile to be
examined in the future studies. One might suggest that
with regard to culture and resources of medical services in
the Middle East there should be two different strategies for
cancer disclosure: one for illiterate or less educated people
and one for people with higher education.
There was no significant relationship between anxiety,
depression and marital status, educational status and gen-
der. A weaker association between demographic parame-
ters and psychiatric morbidity has previously been noted
in the presence of physical illness. It has been suggested
that demographic differences that predispose to anxiety
disorders after life events in the general populationBMC Gastroenterology 2007, 7:28 http://www.biomedcentral.com/1471-230X/7/28
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become less relevant when a very severe stressor such as
cancer occurs [34].
There were no significant association between anxiety and
depression and different gastrointestinal cancer site. In
general when tumors develop in gastrointestinal tract,
special problems in psychological adjustment are posed.
Both patient and family may have to cope with severe eat-
ing problems, significant weight lost, nausea and vomit-
ing, abdominal discomfort, diarrhea or constipation, as
well as other disease related events that are difficult to
manage. These problems result in immediate emotional
distress and concerns [35]. Since the sample in this study
was consisted of heterogeneous gastrointestinal cancer
patients, common symptoms and discomfort in these
people can be a possible reason for lack of relationship
between anxiety, depression and different types of the
cancer studied. In addition the number of some cancers in
the current study were very small and thus to have a better
understanding we recommend that for future studies to
include patients from only one type of gastrointestinal
tract.
A significant relationship was observed between anxiety
and age. This is in accordance with previous studies dem-
onstrating that young people are more distressed than eld-
erly patients by serious illnesses such as cancer [13].
In general, because of the frightening and potentially stig-
matizing nature of the cancer and high prevalence of psy-
chological distress among cancer patients, physicians
should be aware of how much difficulties the patients
experience. They should detect and treat problems earlier
or refer the patient to the psychiatrists more appropriately.
Untreated psychiatric disorder in the presence of co-mor-
bid conditions may result in more frequent clinic visits,
Table 1: Gastrointestinal cancer patients' demographic and clinical characteristics
Knew diagnosis (n = 68) Did not know diagnosis (n = 74) All (n = 142)
No. (%) No. (%) No. (%)
Age
Mean (SD) 50.2 (13.9) 58.2 (13.4) 54.1 (14.8)
Range 23–74 19–76 19–76
Gender
Male 34 (50.0) 45 (60.8) 79 (55.6)
Female 34 (50.0) 29 (39.2) 63 (44.4)
Marital status
Single 7 (10.3) 6 (8.1) 13 (9.2)
Married 59 (86.8) 63 (85.1) 122 (85.9)
Widowed 2 (2.9) 5 (6.8) 7 (4.9)
Educational status
Illiterate 23 (33.8) 55 (74.2) 78 (54.9)
Primary 28 (41.2) 15 (20.3) 43 (30.3)
Secondary 9 (13.2) 3 (4.1) 12 (8.5)
College/university 8 (11.8) 1 (1.4) 9 (6.3)
Cancer site
Esophagus 7 (10.3) 34 (45.9) 41 (28.9)
Stomach 22 (32.4) 20 (27.0) 42 (29.6)
Small intestine 1 (1.5) 4 (5.4) 5 (3.5)
Colon 26 (38.2) 5 (6.8) 31 (21.8)
Rectum 12 (17.6) 11 (14.9) 23 (16.2)
Time since diagnosis (months)
Mean (SD) 4.6 (3.0) 4.1 (3.2) 4.4 (3.2)
Range 1–12 1–12 1–12
Initial treatment
Surgery 54 (79.4) 37 (50.0) 91 (64.1)
Chemotherapy/radiotherapy 9 (13.2) 10 (13.0) 19 (13.4)
Best Supportive care 5 (7.4) 27 (36.5) 32 (22.5)
Anxiety score
0–7 27 (39.7) 48 (64.9) 75 (52.8)
8–21 41 (60.3) 26 (35.1) 67 (47.2)
Depression score
0–7 26 (38.2) 35 (47.3) 61 (43.0)
8–21 42 (61.8) 39 (52.7) 81 (57.0)BMC Gastroenterology 2007, 7:28 http://www.biomedcentral.com/1471-230X/7/28
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Table 3: The results of logistic regression analysis
OR (95% CI) P
Anxiety
Age 0.97 (0.94–1.0) 0.11
Gender
Male 1.0 (ref.)
Female 1.7 (0.78–3.7) 0.17
Marital status
Married 1.0 (ref.)
Single/widowed 0.60 (0.16–2.1) 0.43
Educational Status
Higher 1.0 (ref.)
Secondary 0.84 (0.10–7.5) 0.87
Primary 0.22 (0.32–1.4) 0.11
Illiterate 0.44 (0.06–3.2) 0.42
Cancer site
Esophagus 1.0 (ref)
Stomach 1.4 (0.45–4.7) 0.52
Small intestine 0.34 (0.03–4.2) 0.40
Colon 0.80 (0.21–3.1) 0.75
Rectum 0.62 (0.15–2.5) 0.51
Time since diagnosis 1.1 (0.93–1.2) 0.34
Initial treatment
Surgery 1.0 (ref.)
Chemotherapy/radiotherapy 0.35 (0.10–1.2) 0.11
Best supportive care 1.3 (0.42–3.9) 0.64
Knowledge of cancer diagnosis
No 1.0 (ref.)
Yes 2.7 (1.1–6.8) 0.03
Depression
Age 0.98 (0.95–1.0) 0.34
Gender
Male 1.0 (ref.)
Female 1.3 (0.60–2.8) 0.50
Marital status
Married 1.0 (ref.)
Single/widowed .42 (0.12–1.4 0.16
Educational Status
Higher 1.0 (ref.)
Secondary 0.26 (0.03–2.2) 0.22
Primary 0.17 (0.02–1.2) 0.08
Illiterate 0.73 (0.09–5.3) 0.73
Cancer site
Esophagus 1.0 (ref.)
Stomach 1.9 (0.60–6.1) 0.27
Small intestine 3.2 (0.34–29.8) 0.30
Colon 0.74 (0.19–2.8) 0.66
Rectum 0.95 (0.26–3.4) 0.94
Time since diagnosis 1.0 (0.89–1.2) 0.78
Initial treatment
Surgery 1.0 (ref.)
Chemotherapy/radiotherapy 2.2 (0.65–7.8) 0.19
Best supportive care 1.5 (0.50–4.4) 0.47
Knowledge of cancer diagnosis
No 1.0 (ref.)
Yes 2.8 (1.1–7.2) 0.03
OR = odds ratio, 95% CI = 95% confidence interval, ref. = reference 
group.
Table 2: Anxiety and depression scores for patients with 
gastrointestinal cancer by age, gender, marital status, 
educational status, cancer site and knowledge of diagnosis
Anxiety Depression
Age Mean (SD) Mean (SD)
19–29 8.4 (4.6) 8.0 (4.3)
30–39 10.6 (5.1) 8.9 (3.7)
40–49 9.1 (3.9) 9.4 (4.3)
50–59 7.8 (3.9) 8.5 (4.0)
≥60 6.2 (4.4) 8.1 (3.6)
ANOVA F = 3.87 F = 0.50
P value 0.005* 0.73
Gender
Male 7.0 (4.7) 8.4 (4.0)
Female 8.3 (4.2) 8.6 (3.7)
t-test -1.63 -0.021
P value 0.1 0.83
Marital status
Single 6.8 (2.7) 6.5 (2.9)
Married 7.7 (4.6) 8.6 (3.9)
Widowed 8.1 (5.1) 10.6 (3.1)
ANOVA F = 0.24 F = 2.75
P value 0.78 0.06
Educational status
Illiterate 7.2 (4.3) 8.6 (3.6)
Primary 7.2 (4.6) 7.6 (3.5)
Secondary 10.3 (4.9) 10.1 (5.9)
College/university 9.4 (3.2) 9.1 (3.4)
ANOVA F = 2.33 F = 1.64
P value 0.07 0.18
Cancer site
Esophagus 6.8 (4.5) 8.2 (3.5)
Stomach 8.0 (4.5) 8.9 (3.5)
Small intestine 5.0 (2.8) 8.2 (1.3)
Colon 8.4 (3.2) 7.8 (3.6)
Rectum 7.9 (5.8) 9.3 (5.4)
ANOVA F = 1.11 F = 0.67
P value 0.35 0.61
Initial treatment
Surgery 8.1 (4.4) 8.2 (3.9)
Chemotherapy/radiotherapy 6.6 (4.0) 8.7 (3.1)
Best Supportive care 6.9 (4.8) 8.9 (4.1)
ANOVA F = 1.30 F = 0.36
P value 0.27 0.69
Knowledge of diagnosis
Yes 9.1 (4.2) 9.1 (4.1)
No 6.3 (4.4) 7.9 (3.6)
t-test 3.83 1.94
P value <0.0001 0.05
* Bonferroni correction indicated that only those in age group 30–39 
and ≥60 significantly were differed.BMC Gastroenterology 2007, 7:28 http://www.biomedcentral.com/1471-230X/7/28
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increased costs, extended hospitalizations, and reduce
compliance and quality of life [36].
Conclusion
Overall 47.2% and 57% of patients with gastrointestinal
cancer scored high on both anxiety and depression. Psy-
chological distress was higher in those who knew their
cancer diagnosis. It seems that the cultural issues and the
way we provide information for cancer patients has an
important role in their improved or decreased psycholog-
ical status.
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